Hisamitsu Pharmaceutical Co Inc (HTSUF)
24.56
0.00 (0.00%)
USD |
OTCM |
Jun 17, 16:00
Hisamitsu Pharmaceutical Profit Margin (Quarterly): 4.78% for Feb. 29, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
February 29, 2024 | 4.78% |
November 30, 2023 | 10.30% |
August 31, 2023 | 12.52% |
May 31, 2023 | 12.62% |
February 28, 2023 | 6.09% |
November 30, 2022 | 9.35% |
August 31, 2022 | 14.67% |
May 31, 2022 | 6.18% |
February 28, 2022 | 10.26% |
November 30, 2021 | 4.33% |
August 31, 2021 | 8.57% |
May 31, 2021 | 8.51% |
February 28, 2021 | 10.47% |
November 30, 2020 | 7.27% |
August 31, 2020 | 12.77% |
May 31, 2020 | 0.45% |
February 29, 2020 | 7.81% |
November 30, 2019 | 22.06% |
August 31, 2019 | 16.49% |
May 31, 2019 | 6.54% |
February 28, 2019 | 14.39% |
November 30, 2018 | 12.57% |
August 31, 2018 | 15.90% |
May 31, 2018 | 10.30% |
February 28, 2018 | 8.43% |
Date | Value |
---|---|
November 30, 2017 | 17.88% |
August 31, 2017 | 15.28% |
May 31, 2017 | 10.18% |
February 28, 2017 | 5.68% |
November 30, 2016 | 25.66% |
August 31, 2016 | 13.11% |
May 31, 2016 | 11.87% |
February 29, 2016 | 6.23% |
November 30, 2015 | 14.91% |
August 31, 2015 | 13.66% |
May 31, 2015 | 8.91% |
February 28, 2015 | 10.31% |
November 30, 2014 | 12.94% |
August 31, 2014 | 14.19% |
May 31, 2014 | 10.59% |
February 28, 2014 | 6.11% |
November 30, 2013 | 14.59% |
August 31, 2013 | 15.30% |
May 31, 2013 | 20.27% |
February 28, 2013 | 10.70% |
November 30, 2012 | 16.05% |
August 31, 2012 | 15.35% |
May 31, 2012 | 10.42% |
February 29, 2012 | 11.08% |
November 30, 2011 | 21.90% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
0.45%
Minimum
May 2020
22.06%
Maximum
Nov 2019
9.76%
Average
9.35%
Median
Nov 2022
Profit Margin (Quarterly) Benchmarks
Takeda Pharmaceutical Co Ltd | -0.29% |
Nxera Pharma Co Ltd | -71.16% |
PeptiDream Inc | -19.94% |
Healios KK | -24.24K% |
AnGes Inc | -1.61K% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | 5.30% |
Return on Assets | 4.30% |
Return on Invested Capital | 5.27% |
Gross Profit Margin (Quarterly) | 52.39% |
Operating Margin (Quarterly) | 2.31% |
Return on Net Operating Assets | 12.55% |